Jointown Pharmaceutical Group Co Ltd
SSE:600998
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jointown Pharmaceutical Group Co Ltd
Accounts Payable
Jointown Pharmaceutical Group Co Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Accounts Payable
¥52.9B
|
CAGR 3-Years
47%
|
CAGR 5-Years
28%
|
CAGR 10-Years
23%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Accounts Payable
¥150.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Accounts Payable
¥61.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Accounts Payable
¥12.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
21%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Accounts Payable
¥8.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Accounts Payable
¥20.5B
|
CAGR 3-Years
36%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
|
Jointown Pharmaceutical Group Co Ltd
Glance View
In the sprawling landscape of the Chinese pharmaceutical industry, Jointown Pharmaceutical Group Co. Ltd. has emerged as a significant player, knitting together a vast network that facilitates the distribution of pharmaceutical products across the nation. Founded in 1999 and headquartered in Wuhan, Jointown has adeptly navigated the complexities of China's healthcare demands, becoming the country's largest privately-owned pharmaceutical wholesaler. The company’s operations span the procurement, distribution, and sale of a myriad of pharmaceutical products, medical devices, and healthcare supplies, effectively serving hospitals, clinics, and pharmacies through its extensive logistics and distribution channels. By leveraging cutting-edge technology to enhance its supply chain efficiency, Jointown ensures timely delivery and accessibility of medicines across urban and rural areas, thereby playing a pivotal role in supporting China's healthcare system. Jointown’s business model capitalizes on its robust logistical capabilities and comprehensive distribution network, which underpin its revenue streams. Through strategic partnerships with numerous domestic and international manufacturers, the company offers an impressive portfolio of pharmaceutical and healthcare products, maintaining a careful balance between proprietary and third-party offerings. This diversity in product offerings not only stabilizes its revenue base but also positions Jointown favorably in a highly competitive market. By continually expanding its e-commerce platforms and digital interfaces, the company fosters direct interaction with consumers, enhancing customer engagement and opening new revenue avenues. In essence, Jointown's prowess lies in its ability to integrate traditional distribution methods with innovative digital solutions, ensuring the company’s sustained growth and relevance in the ever-evolving pharmaceutical industry.
See Also
What is Jointown Pharmaceutical Group Co Ltd's Accounts Payable?
Accounts Payable
52.9B
CNY
Based on the financial report for Sep 30, 2025, Jointown Pharmaceutical Group Co Ltd's Accounts Payable amounts to 52.9B CNY.
What is Jointown Pharmaceutical Group Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
23%
Over the last year, the Accounts Payable growth was 15%. The average annual Accounts Payable growth rates for Jointown Pharmaceutical Group Co Ltd have been 47% over the past three years , 28% over the past five years , and 23% over the past ten years .